News | February 10, 2026
Neuland Laboratories reports Rs 1,264.5 crore revenue for 9MFY26
The revenues this quarter are in line with the outlook we envisaged for the year
The revenues this quarter are in line with the outlook we envisaged for the year
The company’s EBITDA margin remained resilient above 20%
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
The new service delivers end-to-end support, managing every stage of an epigenomics project
This achievement validates global demand and catapults Wanbury into high-growth acceleration
The Poultry Healthcare Division delivered a strong performance, posting 32% revenue growth in Q3 FY26 and 17% growth over the nine-month period
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
The state-of-the-art commercial production plant will be built on a 95-acre site in Saarlouis, acquired at the end of 2024
Subscribe To Our Newsletter & Stay Updated
